SYNAPTICS Inc 4
4 · SYNAPTICS Inc · Filed Oct 1, 2015
Insider Transaction Report
Form 4
SYNAPTICS IncSYNA
Sewell Bretton
SVP, Corporate Development
Transactions
- Exercise/Conversion
Common Stock
2015-09-30$46.50/sh+2,088$97,092→ 15,156 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2015-09-30−1,458→ 417 totalExercise: $42.57Exp: 2020-04-29→ Common Stock (1,458 underlying) - Exercise/Conversion
Common Stock
2015-09-30$42.57/sh+1,458$62,067→ 13,068 total - Sale
Common Stock
2015-09-30$78.01/sh−3,200$249,632→ 11,956 total - Sale
Common Stock
2015-09-30$81.88/sh−3,546$290,346→ 8,410 total - Exercise/Conversion
Common Stock
2015-09-30$26.04/sh+3,200$83,328→ 11,610 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2015-09-30−3,200→ 18,151 totalExercise: $26.04Exp: 2019-05-22→ Common Stock (3,200 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2015-09-30−2,088→ 1,493 totalExercise: $46.50Exp: 2020-10-28→ Common Stock (2,088 underlying)
Footnotes (4)
- [F1]The shares were sold pursuant to a 10b5-1 Trading Plan dated August 29, 2014.
- [F2]25% of the total number of shares subject to the option vested and became exercisable on the twelve month anniversary of the May 22, 2012 grant date, and 1/48th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable on the 22nd day of each month thereafter until fully vested on May 22, 2016.
- [F3]1/36th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable on the 29th day of each month following the date of grant until fully vested on April 29, 2016.
- [F4]1/12th of the total number of shares subject to the options vested or shall vest and became or shall become exercisable each quarter following the October 28, 2013 grant date until fully vested on October 28, 2016.